New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.

European stocks closed lower on Friday, continued to be weighed down by concerns about global economic growth following U.S. President Donald Trump's tariff ...

The US bone and joint health supplements market is experiencing substantial growth, driven by evolving consumer preferences ...

Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

The "Enterprise Tech Ecosystem Series: Haleon - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Haleon's tech activities, including its ...

Retail marketing campaigns that engaged consumers at the point of purchase took centre stage at the 2025 Shop! ANZ Retail ...

Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated ...

Commonwealth Equity Services LLC lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.3% in the fourth ...

In early corporate news, SSE names Chief Commercial Officer Martin Pibworth as its new chief executive designate, while WH Smith agrees the sale of its UK High Street business. Here is what you need ...

Cocoa extract supplementation among older adults had no effect overall on the occurrence of age-related macular degeneration ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...